September 24, 2012
Ailing drugmaker K-V Pharmaceutical Co. on Thursday told a New York federal judge that creditor Hologic Inc. is trying to skirt bankruptcy law by seeking worldwide rights to Makena, a drug that prevents premature birth, and is wrongly suggesting the potential blockbuster medicine is rapidly losing value.
September 14, 2012
A New York bankruptcy judge on Friday approved K-V Discovery Solutions Inc.'s request to access its cash collateral after the life science company's largest creditor withdrew its objections to the motion.
September 06, 2012
K-V Pharmaceutical Co. creditor Hologic Inc. asked a New York bankruptcy judge Wednesday to lift the automatic stay so it could pursue its rights with respect to its first lien on K-V's biggest asset, preterm-birth drug Makena, saying the drug's value is declining.
August 09, 2012
A New York bankruptcy judge on Thursday approved new debtor K-V Pharmaceutical Co.'s request to access $31.4 million in cash collateral to help it maneuver through the first 15 days of its bankruptcy and continue to pay employee wages and other necessary expenses.